Werbung
Werbung

PLSE

PLSE logo

Pulse Biosciences, Inc Common Stock (DE)

14.47
USD
Gesponsert
-0.25
-1.73%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

14.60

+0.13
+0.89%

PLSE Ergebnisberichte

Positives Überraschungsverhältnis

PLSE übertreffen die 9 der letzten 22Schätzungen.

41%

Nächster Bericht

Datum des nächsten Berichts
25. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$255.00K
/
-$0.32
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+196.51%
/
+14.29%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/
+88.24%

Pulse Biosciences, Inc Common Stock (DE) earnings per share and revenue

On 05. Nov. 2025, PLSE reported earnings of -0.28 USD per share (EPS) for Q3 25, beating the estimate of -0.31 USD, resulting in a 8.29% surprise. Revenue reached 86.00 tausend, compared to an expected 510.00 tausend, with a -83.14% difference. The market reacted with a -3.32% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.32 USD, with revenue projected to reach 255.00 tausend USD, implying an increase of 14.29% EPS, and increase of 196.51% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
06. Jan. 2026 For Q2 26
Estimate
-$0.10
Aktuell
$0.00
Überraschung
+100.00%
FAQ
For Q3 2025, Pulse Biosciences, Inc Common Stock (DE) reported EPS of -$0.28, beating estimates by 8.29%, and revenue of $86.00K, -83.14% below expectations.
The stock price moved down -3.32%, changed from $16.27 before the earnings release to $15.73 the day after.
The next earning report is scheduled for 25. März 2026.
Based on 3 analysts, Pulse Biosciences, Inc Common Stock (DE) is expected to report EPS of -$0.32 and revenue of $255.00K for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung